Ann Van de Velde unpaid staff

Publications Ann Van de Velde

Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives

Source
EJHaem - ISSN 2688-6146-5:5 (2024) p. 1096-1099
Author(s)
    Bert Heyrman, Stef Meers, Selim Sid, Natalie Put, Koen Theunissen, Koen Van Eygen, Nathan De Beule, Maxime Clauwaert, Helena Maes, Alexander Salembier, Jan Lemmens, Ann Van de Velde, Dominik Selleslag, Jason Bouziotis, Ann De Becker, Sébastien Anguille

Combined results of two cross-sectional surveys on the participation in clinical trials and the e-consent procedure in the landscape of haematology

Source
Clinics and practice - ISSN 2039-7275-13:6 (2023) p. 1520-1531
Author(s)

Disease perception is correlated with health-related quality of life in patients suffering from myelodysplastic syndromes : results of the Belgian Be-QUALMS study

Source
Cancers - ISSN 2072-6694-15:13 (2023) p. 1-11
Author(s)

Ciltacabtagene autoleucel for patients with triple-class exposed multiple myeloma : adjusted comparison of CARTITUDE-1 patient outcomes versus real-world clinical practice

Source
HemaSphere - ISSN 2572-9241-6:12 (2022) p. 1-4
Author(s)
    Michel Delforge, Marie-Christiane Vekemans, Julien Depaus, Nathalie Meuleman, Ann Van de Velde, Isabelle Vande Broek, Sophie Vandervennet, Sandra Van Hoorenbeeck, Evelien Moorkens, Danielle Strens, Joris Diels, Francesca Ghilotti, Benjamin Haefliger, Sander Dalhuisen, William Deraedt, Sébastien Anguille